la) and transforming growth factor-p (TGF-B) (transcriptional and posttranscriptional) in BM stroma. Clonogenic assays with NK-A (IO-' mol/L) and either anti-MIP-la or anti-TGF-pl indicate that these cytokines partly contribute to the inhibition, suggesting that these two negative hematopoietic regulators exert part of the inhibition by NK-A on CFU-GM. The findings of two closely related neuropeptides, derived from the same gene, exerting opposite effects on myeloid colonies suggest that neuropeptides, by themselves could be important factors in hematopoietic regulation. 0 1996 by The American Society of Hematology.
ligand-binding studies indicate subtypes of each NK-R." SP, NK-A, and NK-B exhibit binding preferences for NK-lR, NK-2R, and NK-3R, re~pectively.'~ The NK-Rs are expressed in immune and hematopoietic cells and belong to a family of G-protein-coupled receptors with seven transmembrane-spanning segments." Macrophages express the classical NK-Rs and also, a nonneurokinin receptor coupled to Gi-protein."^'" We have recently reported evidence for NK-R subtypes in human bone marrow (BM) stroma." SP has been the most studied tachykinin because it is used as a model in most of the reports pertaining to immunemediated functions by this family of peptides. SP is involved in inflammatory responses: stimulation of lymphocytes and regulation of tissue enhancement of phagocytosis:' chemotaxis and release of induction of mast cell degranulation:' enhancement of immunoglobulin prod~ction,'~ and function as a terminal differentiation cofactor for B cells.'" SP induces cytokine production in immune and hematopoietic cells. These include interleukin-1 (IL-l), 1L-2, IL-3, IL-6, tumor necrosis factor-a (TNF-a), granulocytemacrophage colony-stimulating factor (GM-CSF), and interferon-y ( I F N -~) .~~-~"
The field of neuroimmunology has been well established. However, the concept for a neurohematopoietic link is based on limited s t~d i e s .~.~,~' -~ We have shown that SP exerts in vitro stimulatory effects on hematopoiesis, mostly mediated by growth factors and involves the BM ~t r o m a .~ Recently, we implicated further the stroma by demonstrating that SP can induce a key hematopoietic growth factor, c-kit ligand in BM stroma." Most of the hematopoietic effects exerted by SP involve an NK-1-like re~eptor.~ In this study, we determined the hematopoietic effects of another tachykinin, NK-A, thus expanding the field of neurohematology. Compared with SP, in this study, we report that NK-A exerts inhibitory effects on myeloid colonies mediated mostly by the stroma. We have also found that NK-A, through an NK-2-like receptor mediates the induction of two negative hematopoietic growth factors, macrophage inflammatory protein-la (MIP-1a)45, 46 and transforming growth factor$ (TGF-p),J7.4X suggesting that this induction may be part of its inhibitory mechanism. Immediately before use, they were diluted in serum-free tissue culture medium. SP, NK-A, and spantide were dissolved in endotoxin-free distilled water, followed by solubilization of nitrogen and then were aliquoted in siliconized microcentrifuge tubes and stored at -70°C. Reconstituted NK-A, SP, and spantide were used within 1 month.
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MATERIALS AND METHODS
NK-
Murine monoclonal antihuman GM-CSF (anti-hGM-CSF), recombinant human (rh) GM-CSF, erythropoietin (rhEpo), hIL-3, rhMIP-la, and rabbit plyclonal anti-MIPla were generously provided by the Immunology Department of Genetics Institute (Cambridge, MA). TGF-P, purified from human platelets and rabbit polyclonal antihuman TGF-P (anti-hTGF-P) were purchased from R&D Systems (Minneapolis, MN). According to manufacturer's specification, the hTGF-P antibody exhibits high specificity for neutralization of hTGF-Pl. Also in our laboratory, we have shown that this antibody has very low reactivity with hTGF-P2 and hTGF-P3 (unpublished observations, December 1991).
BM aspirates were taken from the posterior iliac crest from healthy volunteers, after obtaining informed consent. Aspirates were placed into preservative-free heparin, and low-density BM mononuclear cells (BMNCs) were separated by Ficoll-Hypaque (Pharmacia LKB Biotechnology, Piscataway, NJ) density gradient. Total or stroma-depleted BMNCs (1 X IO5), in duplicate, were plated in methylcellulose for erythroid (E) (burstforming unit [BFUI-E and colony-forming unit [CFUI-E) and myeloid (CFU-GM) progenitor cells as previously de~cribed.~' Cells were cultured in the presence of various concentrations of NK-A to lo-'' mom). CFU-GM cultures were supplemented with 2 U/mL of rhGM-CSF and erythroid cultures were supplemented with 2 U of hIL-3, and 2 U of rhEpo. In each assay, control cultures were established with cells cultured without NK-A. The number of colonies obtained in the control cultures ranged from 120 to 220 for CFU-GM, 80 to 125 for CFU-E, and 80 to 140 for BFU-E. Colonies were enumerated at different times on the basis of their morphology. CFU-GM and CFU-E colonies were enumerated on day 10 and BFU-E on day 18.
Cells from BM aspirate (10 x lo6) were plated in 25 mL tissue culture flasks (Falcon 3109) in culture medium that consisted of a minimal essential medium (a-MEM; GIBCO-BRL, Grand Island, NY), 12 Mononuclear cells were separated from BM aspirate by Ficoll-Hypaque density gradient, and stromal-forming cells were depleted by passage twice through nylon wool columns as d e~c r i k d .~* Columns were prepared by loosely packing approximately 0.6 to 0.7 g of scrubbed nylon wool (Fenwall Laboratories, Deefield, IL) in a 10-mL syringe. Columns were equilibrated with prewarmed (37°C) RPMI-1640 containing 5% FCS. Cells were resuspended at 5 X 107/mL in similar medium and then were added to the column. Columns were then incubated at 37°C for 45 minutes. After this incubation period, nonadherent cells were eluted with similar prewarmed medium. This passage through the nylon wool columns was repeated. Recovered cells did not form stroma even up to 4 weeks in culture.
Noncontact cultures were prepared as described elsewhere. Nonadherent cells were removed from confluent BM stroma after which stroma was washed with endotoxin-free, tissue culture grade, phosphate-buffered saline (PBS; Cellgro; Mediatech). After washing, 5 mL serum-free medium was added to each flask. Serum-free medium contains a-MEM + serum-supplement (GMS-A; GIBCO). Stromal cultures were stimulated with NK-A and either of the following antagonists: CP-96,345-1, SR 48968, or spantide. Samples to be assayed for cytokine protein levels were incubated for the optimum time period of 3 days, whereas mRNA induction was analyzed from stroma stimulated for 1 day. These specific incubation times were chosen on the basis of cytokine induction in time course experiments ranging from day 1 to day 5 (data not shown).
Released cytokines were analyzed in the supernatants, whereas cell-associated cytokine levels were assayed in homogenized stromal extracts. Supematants were concentrated one tenth of the original volume by lyophilization in a Savant Speed Vac Concentrator (Hicksville, NY). To obtain cell-associated cytokines, supernatants were first removed and 0.5 mL protease inhibitors (0.2 p m o m pepstatin, 5 p m o m leupeptin, and 10 pmoVL phenylmethylsulfonly fluoride [PMSF]) immediately were added. Cells were scraped and then sonicated (Sonics Materials Inc, Danbury, CT). After sonication, cell-free fractions were obtained by centrifugation at 15,OOOg for 15 minutes and then were frozen at -70°C until ready to be assayed for cytokine levels.
The mink lung epithelial cell line (CCL 64) was obtained from Dr Michael Newman (Sandoz Research Institute, East Hanover, NJ) and was maintained in RPMI-1640 (GIBCO) supplemented with 2 mmol/L glutamine, 15 mmol/ L HEPES, 10% FCS, (Hyclone), and penicillin-streptomycin (P-S; 50 IU-50 pg/mL). Glutamine, HEPES, and P-S were purchased from Cellgro, Mediatech. Quantitation of TGF-P was performed as preDepletion of stromal cells in BM mononuclear cells.
Noncontact stromal cultures.
Cytokine induction in BM stroma.
Bioassay for TGF-P quantitation.
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 100 RAMESHWAR AND GASCON viously described.s4 The assay is based on growth inhibition of the CCL 64 cell line. CCL 64 cells (5 X lo3) were added to 24-well tissue culture plates (Falcon 3047) in a total volume of 0.5 mL of RPMI-1640 supplemented with 2 mmol/L glutamine, 10% FCS, and 15 mmoUL HEPES. Cells were incubated for 1 day, after which 50 and 100 pL triplicate samples of supernatants were added to the wells. Cultures were incubated for an additional 3 days, after which the total number of viable cells per well were enumerated. The levels of TGF-P were determined with a standard curve of viable CCL 64 cells as a function of known TGF-/? concentrations (0.02 to 20 ng/ mL). Parallel experiments were performed with supernatants in the presence of neutralizing polyclonal anti TGF-P which exhibits high specificity for human TGF-01. Because TGF-p standards were dissolved in 0.05N HCI, vehicle controls were performed. At the end of the assay period, the vehicle and media controls resulted in comparable cell numbers (1.25 X IO5 to 1.50 X lo5).
Enzyme-linked immunosorbent assay (ELISA). MlP-la and TGF-P were quantitated by direct ELISA. The antigens included various concentrations (0.25 to 500 ng/mL) of TGF-PI, rhM1P-la, and four serial dilutions of each unknown sample diluted in Tris buffer (pH 8.9 ). The standards were tested in duplicate and the unknowns in triplicate. Diluents of the antigen (50 pL) were added to Immulon-l 96-well flat-bottomed plates (Dynatech Laboratories Inc, Chantilly, VA) overnight at 4°C. The next day, plates were washed in PBS containing Tween 20 (0.1 %) and then were blocked with 5% nonfat milk. Antigens were then incubated with rabbit polyclonal anti-MIP-la or TGF-P (4 pg/mL) that were diluted in PBS containing i% bovine serum albumin (BSA; US Biochemicals, Cleveland, OH) overnight at 4°C. The antibodies were detected with biotinylated horse antirabbit IgG (Vector Laboratories, Burlingame, CA). The latter was amplified with Avidin D (20 pg/mL; Vector Laboratories), followed by incubation with biotinylated conjugated alkaline phosphatase (0.2 U/mL; Vector Laboratories). Bound enzyme was detected with Sigma 104 phosphatase substrate dissolved in 0.5 mmol/L diethanolamine buffer containing 0.5 mmoW magnesium chloride, and 0.02% sodium azide (all reagents from Sigma). Color development was measured at a wavelength of 405 nm on an EL 31 Is microplate reader (Bio-Tek Instruments Inc, Winooski, VT).
BM stroma was stimulated for 1 day as described above, and total RNA was extracted using the acid guanidium thiocyanate-phenol-chloroform extraction method, as previously described?' Total RNA (20 r g ) was resuspended in denaturing conditions (formamide/formaldehyde) and electrophoresed on 1.2% agarose containing 4.8% formaldehyde and ethidium bromide. RNA ladders (0.24 to 9.5 and 0.16 to 1.77 kb) were used as molecular weight markers. RNA was transferred to nylon membranes (S&S Nytran, Keene, NH) overnight, in 1OX sodium chloride/sodium citrate (SSC) buffer and then was cross-linked with UV illumination and baked for 2 hours at 80°C under vacuum. Membranes were prehybridized, followed by hybridization with complementary DNA (cDNA) probes for hMIP-la, hTGF-01, and 28s ribosomal RNA (rRNA). Probes were randomly labeled using the Prime-IT I1 random primer labeling kit (Stratagene, La Jolla, CA). After hybridization, membranes were washed twice at room temperature with 2X SSC containing 0.1% sodium dodecyl sulfate (SDS) followed by one wash lasting 20 minutes at 37' C with buffer of similar stringency. Membranes were exposed to x-ray films and then developed by autoradiography. Hybridized membranes were stripped then rehybridized with each cDNA probe. Membranes were developed by autoradiography after 24 hours. Ethidium bromide visualization of rRNA andlor hybridization with 28s cDNA probe was used as loading controls and also for normalization. Comparison of autoradiograms was performed by densitometric scanning.
Northern analysis.
Human cDNA probes for MIP-la and TGF-pl were generously provided by Genetics Institute. The cDNA insert for MIP-lu (0.7 kb) is present in the Psr I site in the EMC2Bl vector and, TGF-PI (0.5 kb) is present in pSP64 between Sma I-BamHI sites. cDNA probed for 285 rRNA (0.7 kb) was purchased from American Type Culture Collection (Rockville, MD) and was excised from pBluescript I1 SK(-) at EcoRI site.
The nuclear run-on assay was performed as described.5" Stromal cells (lo') in a confluent 25-cm' tissue culture flask were stimulated for 8 hours in sera-free media (see above) with either IO-" mol& NK-A or IO-' mol/L NK-A containing IO-' mol/ L of either of the following antagonists: CP-96,345-I , SR 48968, or spantide. For each stimulus, the new transcripts in IO' nuclei were labeled with 250 pCi [a-32P]UTP (800 Ci/mmol/L; NEN, Boston, MA). Transcripts were purified on Sephadex G50 columns and I O7 dpm/mL used to hybridize 2 pg of cDNA for 28s rRNA, MlPla, and TGF-PI . Information on cDNA probes is described above.
Hybridization temperatures for 28s rRNA, MIP-la. and TGF-P I were 37, 42, and 42"C, respectively. Membranes were exposed for I week to x-ray films that were developed by autoradiography.
The statistical significance was determined using one-way repeated measures, analysis of variance (ANOVA) followed by Tukey's multiple comparison at P < .05. All results are given as two-tailed P values.
Nuclear run-on assay.
Statistical analysis.
RESULTS
Effects ojNK-A on hematopoietic progenitors. We have previously implicated an NK-1 -like receptor in the stimulatory effects observed by SP on hematopoietic progenitor^.^ Subsequent studies in our laboratory indicate that there may be subtypes of NK-R in the BM." Other studies indicate the presence of nonneurokinin receptors in monocytes and subtypes of SP-binding sites in other t i s s~e s . ' *~'~~~~ SP and NK-A are derived from the same PPT-I gene and the spliced product appears to be tissue-specific. '* Furthermore, the PFT-I gene can be induced in neural and nonneural sources. Recently, a fourth spliced variant that is capable of producing NK-A has been cloned in the rabbit.58 These facts lead us to determine if NK-A, another product derived from the PPT-I gene, has an effect on myeloid and erythroid progenitors. This question was addressed by performing short-term BM cultures in the presence of various NK-A concentrations ( to lo-'* mom). Whereas S P was stimulatory to CFU-GM, the effect of NK-A was significantly inhibitory ( P < .05) at the optimum concentration of IO-' to 10."' moYL (Fig 1) . Although NK-A exerted a significant stimulatory effect on CFU-E ( P < .05), the effect was less stimulatory than for SP (Fig 1 ) . The effects on early erythroid (BFU-E) were slightly stimulatory, but significant ( P < .05). with approximately 45% as the optimum at 10.' moYL (Fig 1) compared with 80% for similar concentration of SP, previously reported7 and, repeated with cultures assayed in parallel with NK-A in the current studies. These results suggest that the hematopoietic effects exerted by NK-A depend on the particular committed progenitor cell as indicated by its stimulation on erythroid progenitors and its inhibition on CFU-GM. Furthermore, it is unlikely that the inhibitory effects could be due to cell death because parallel cultures in which cells ( 99%) determined by trypan blue exclusion. Furthermore, the total number of cells in cultures did not change from day 0 to day 7 (1 x IO6 2 151/mL), (n = 5, mean ? SD).
Role of BM stroma in NK-A-mediated hematopoietic effects. Most of the hematopoietic effects by SP were mediated by the BM adherent cells and through the release of at least the growth factors necessary for the in vitro cultures, IL-3, and GM-CSF. ' We have therefore determined if the hematopoietic effects exerted by NK-A involve the BM stroma. We repeated the methylcellulose cultures with stroma-depleted cells and found that the inhibitory effects on CFU-GM were blunted (Fig 2) . In the absence of stromal cells, the effects exerted by NK-A on the erythroid colonies were much less stimulatory (Figs 1 and 2) .
To address the role of the stroma in NK-A-mediated inhibition of CFU-GM, we cultured stroma-depleted BMNCs in the presence of y-irradiated stromal cells in transwell cultures. Both inner and outer chambers contained IO-' mol/L NK-A. At days 3.5, and 7, aliquots of BMNCs were washed and then cultured in duplicate short-term methylcellulose for CFU-GM (1 X IO' per culture). Although NK-A was absent in these subcultured methylcellulose assays, we found that CFU-GM colonies were inhibited (Fig  3) . The inhibition observed in these cultures and in methylcellulose cultures was similar (Fig I) . Also, day 5 appears to be less stimulatory than days 3 and 7 (Fig 3) . These results suggest that a soluble factor(s) is partly responsible for this inhibition and that direct contact with the stroma is not required.
Induction of MIP-la and TGF-BI in BM stroma by NK-A. Experimental evidence indicates that soluble factors released from BM stroma may be responsible for the inhibition on CFU-GM by NK-A (Fig 3) . Because SP has been implicated in cytokine production, we investigated if its related member, NK-A, could be inducing known negative hematopoietic inhibitors such as MIP-la and TGF-P, both suppressive to myeloid colonies.4s4x Therefore, we stimulated BM stroma with mol/L NK-A and studied the induction of these two cytokines at the protein and mRNA levels. We observed that NK-A induced the two cytokines in both parameters Days in transwell ( Table 1 and Fig 4) . MIP-la and TGF-P proteins were released in the sera-free media and also associated with the stroma (Table I) . Parallel studies with m o m SP indicated minimal quantities of cell-associated TGF-P and MIPl a production (TGF-P: 250 2 28 pg/mL; MIP-la: 35 t 12 ng/mL).
Densitometric scans of the autoradiographic bands in the Northern blots (Fig 4B) were normalized to 28s rRNA. The ratio of stimulated over unstimulated messenger RNA (mRNA) indicated a three-to fourfold increase and is expressed on the vertical axis (Fig 4A) . BM stroma cultured without NK-A or antagonists represents unstimulated cultures. For both protein and mRNA, specific NK-2R antagonist blocked most of the these two cytokines, whereas specific NK-1R antagonists had no effect (Table 1 and Fig 4) . These results suggest that the induction of MIP-l a and TGF-PI by NK-A is mediated by NK-2-like receptors.
The stroma is known to constitutively produce baseline cytokines. Therefore, we investigated if the induction of MIP-la and TGF-PI was due to increased transcriptional rate. This was addressed in nuclear run-off assay. BM stroma was stimulated for 8 hours, similar to the method described for Northern analysis. New transcripts were examined for MIP-la and TGF-PI mRNA. We found that the transcriptional rate for both cytokines was increased and that SR 48968 and spantide blunted the transcriptional rate of MIPla and TGF-P1 (Fig 5) . CP-96,345 had no effect (Fig 5) .
Because similar results were observed in Northern analysis and at the level of protein induction, the results suggest that NK-A mediates the induction of MIP-la and TGF-PI through an NK-2-like receptor.
Role of TGF-P and MIP-la in NK-A-mediated suppression of CFU-GM. In the absence of accessory cells, TGF-P and MIP-1 a can induce the proliferation of mature progenitor cells and inhibit primitive CD34+ cell^.^^^^ However, in the presence of cytokines, TGF-P shows different effects on the proliferation of CD34' cells. 61 We determined the relevance of TGF-P and MIP-la in the inhibition of CFU-GM by NK-A in four different experiments. BMNCs were cultured for CFU-GM in the presence of molL NK-A and 2 pg/mL of anti-TGF-P1 or 2 pg anti-MIP-la. These concentrations were able to exert maximum inhibition within the range of antibodies added to the cultures (0.2 to 20 pg). NK-A alone resulted in 49% t 5% (mean t SD) suppression whereas, those with anti-TGF-P1 and anti-MIP-la resulted in 27% t 4% and 16% t 5% inhibition, respectively. These results suggest that although MIP-la and TGF-P are involved in NK-A-mediated suppression of CFU-GM, other factor(s)/mechanism(s) is (are) involved.
DISCUSSION
Our results indicate that NK-A inhibits CFU-GM colonies but stimulates early (BFU-E) and late (CFU-E) erythroid colonies. The effects are bell shaped with maximum effects BM stroma was stimulated for 3 days in serum-free medium with either NK-A or (1) NK-A and specific NK-1-receptor antagonist ICP-96,3451, (2) NK-A and specific NK-2-receptor antagonist (SR48968), or (3) NK-A and a pantachykinin antagonist (spantide). TGF-8 levels were quantitated in a bioassay with the CCL64 cell line and also by ELISA. MIP-la levels were determined by ELISA. Released cytokine was quantitated in the culture media and cell-associated levels as- For personal use only. on September 24, 2017. by guest www.bloodjournal.org From at to IO-'" m o m (Fig 1) . The BM stroma appears to mediate most of the NK-A inhibitory effects (Fig 2) . The stroma also partly mediates the stimulatory effects on erythroid colonies because in its absence, NK-A exerts less stimulation (Fig 2) . Transwell cultures indicate that soluble factor(s), not direct contact with the stroma, is (are) responsible for the stroma-dependent inhibition on CFU-GM (Fig  3) . At least two hematopoietic suppressive factors, TGF-0 1 and MIP-la are induced in BM stroma by NK-A, mostly through increased transcriptional rate (Figs 4 and 5) . The induction of these two cytokines by NK-A is mediated by NK-2-like receptors (Fig 4) .
The hematopoietic effects exerted by NK-A in this study are different than previously reported for SP, a related ta~hykinin.~ These results are intriguing because both tachykinins are derived from the same gene, and the spliced product is tissue-specific.62 Furthermore, the hematopoietic effects exerted by NK-A are observed at low concentrations ( to IO-'' mol/L), suggesting that these effects may have physiologic relevance. Although we have found that NK-A induces two negative hematopoietic factors, TGF-0 and MIPla in stroma, this induction may represent only part of the mechanism involved in the suppression of CFU-GM. Other sources of inhibitory factors as well as other mechanisms are plausible. The CD34+ cells themselves could be another source of TGF-0 because previous studies reported that a subset of these cells can produce this cytokine.h3.M The experimental evidence suggests that positive factors are concommittantly being produced because in spite of TGF-0 production, a known suppressor of BFU-EF a stimulatory effect is observed in these colonies (Fig 1) . Also, clonogenic assays for CFU-GM with anti-TGF-0 and MIP-la indicate that other factors and/or mechanisms are involved in the suppression of CFU-GM. Other studies in our laboratory suggest that the NK-I and NK-2 receptors on BM progenitors mediate opposite proliferative effects (unpublished observations, May 1995). Also, SP mediates a stimulatory effect on BM progenitors through an NK-1-like receptor' and on NK-A through an NK-2-like receptor (Table I, Figs 3 through 5) . Similar to the distinct intracellular pathways mediated by the NK-I receptor, it is plausible that NK-I and NK-2 receptors could be mediating different intracellular pathways that translate into distinct biologic effects on the myeloid progenitors. The NK-I receptor is linked to the inositol triphosphate (IP3)-phosphokinase C and cyclic adenosine monophosphate,w and the biologic effects exerted by this receptor depend on the intracellular signals. Comparison of the pathways for NK-1 and NK-2 receptors will add to an understanding of the hematopoietic effects observed for NK-A in this report. Different hematopoietic effects by SP and NK-A could be a natural regulatory mechanism by the tachykinins to maintain homeostasis, following the pattern of biological systems that need positive and negative factors for their regulation.
Our findings, as well as those by others, indicating the ability of cytokines to modulate the induction of SP receptor further add complexity to the hematopoietic regulatory netOther reports show that cytokines and neurotrophic Cytokines are known regulators of hematopoiesis. The functions demonstrated by NK-A in this report, which include cytokine induction and effects on BM progenitors, could very well give the neuropeptides a physiologic role in the general hematopoietic regulatory network. Considering that SP, NK-A, and other neuropeptides can induce cytokines, it is tempting to speculate that by themselves, the neuropeptides may be able to modulate a tight hematopoietic network.
